0

Close
 
Upcoming Allied Market Research
2023
Blood Group Typing Market

Blood Group Typing Market

by Product (Consumables, Instruments, Services), by Technique (PCR-based and Microarray Techniques, Assay-based Techniques, Massively Parallel Sequencing Techniques, Other Techniques), by Test Type (Antibody Screening, HLA Typing, Cross-matching Tests, ABO Blood Tests, Antigen Typing) and by End User (Hospitals, Blood Banks, Clinical Laboratories, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A02526
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Blood Group Typing Market

Request Now !

Blood group typing is the process of identifying and classifying a persons blood group into one of the classes (such as those designated A, B, ABor O) by means of laboratory tests. Blood group typing test is essential to transfuse blood, test donor blood compatibility with recipient patient, and determine the presence of Rh factor. Not all blood types are compatible, so it is important to know the blood group of an individual. Blood typing helps determine the condition of hemolytic disease of the newborn (HDN) in pregnant women, thereby increasing the demand for such tests. Receiving blood thats incompatible with an individuals blood type (having foreign antigens) could cause a dangerous immune response (by creating antibodies against the foreign antigen). This majorly increases the demand for the blood group typing market.

The key factors that drive the market growth include the rise in demand for blood group typing for pregnancy & prenatal testing, rise in number of blood donations through education & blood donation campaigns, and increase in number of patients who need transfusion due to accidents and trauma. In addition, growth in application of blood group typing in forensic sciences is further expected to catalyze the market growth. However, lack of awareness and dearth of skilled and trained professionals can lead to misleading transfusion thus, leading to decline in sales of blood bank reagents and ultimately hampering the growth of the blood group typing market.

The global blood group typing market can be segmented into type of products, techniques, by test type, end users, and region. Based on products, the market is categorized into consumables, instruments, and services. In terms of technique, it is classified into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. Based on test type, it is subdivided into antibody screening, human leukocyte antigen (HLA) typing, cross matching series, ABO blood tests, and antigen typing. Based on end user, it is divided into hospitals, blood banks, clinical laboratories, and other end users. By geography, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA.

Some of the key players in the market are Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France).

Key Benefits

  • The study provides an in-depth analysis of the global blood group typing market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis to enable the stakeholders to capitalize on prevailing market opportunities.
  • Key market players are profiled and their strategies are analyzed thoroughly, which helps understand the competitive outlook of the market.
  • Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.
  • By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

 Blood Group Typing Market Report Highlights

Aspects Details
By Product
  • Consumables
  • Instruments
  • Services
By Technique
  • PCR-based and Microarray Techniques
  • Assay-based Techniques
  • Massively Parallel Sequencing Techniques
  • Other Techniques
By Test Type
  • Antibody Screening
  • HLA Typing
  • Cross-matching Tests
  • ABO Blood Tests
  • Antigen Typing
By End User
  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Other End Users
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players DIAGAST (France), Quotient, Ltd. (U.S.), Grifols, S.A. (Spain), BAG Healthcare GmbH (Germany), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France), Novacyt Group (France), Bio-Rad Laboratories, Inc. (U.S.)
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: BLOOD GROUP TYPING MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Consumables

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Instruments

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Services

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: BLOOD GROUP TYPING MARKET, BY TECHNIQUE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technique

    • 5.2. PCR-based And Microarray Techniques

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Assay-based Techniques

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Massively Parallel Sequencing Techniques

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Other Techniques

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: BLOOD GROUP TYPING MARKET, BY TEST TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Test Type

    • 6.2. Antibody Screening

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. HLA Typing

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Cross-matching Tests

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. ABO Blood Tests

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Antigen Typing

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: BLOOD GROUP TYPING MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospitals

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Blood Banks

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Clinical Laboratories

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Other End Users

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: BLOOD GROUP TYPING MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Technique

      • 8.2.4. Market Size and Forecast, By Test Type

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Blood Group Typing Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Technique
        • 8.2.7.3. Market Size and Forecast, By Test Type
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Blood Group Typing Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Technique
        • 8.2.8.3. Market Size and Forecast, By Test Type
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Blood Group Typing Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Technique
        • 8.2.9.3. Market Size and Forecast, By Test Type
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Technique

      • 8.3.4. Market Size and Forecast, By Test Type

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Blood Group Typing Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Technique
        • 8.3.7.3. Market Size and Forecast, By Test Type
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Blood Group Typing Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Technique
        • 8.3.8.3. Market Size and Forecast, By Test Type
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Blood Group Typing Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Technique
        • 8.3.9.3. Market Size and Forecast, By Test Type
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Blood Group Typing Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Technique
        • 8.3.10.3. Market Size and Forecast, By Test Type
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Blood Group Typing Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Technique
        • 8.3.11.3. Market Size and Forecast, By Test Type
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Blood Group Typing Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Technique
        • 8.3.12.3. Market Size and Forecast, By Test Type
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Blood Group Typing Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Technique
        • 8.3.13.3. Market Size and Forecast, By Test Type
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Technique

      • 8.4.4. Market Size and Forecast, By Test Type

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Blood Group Typing Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Technique
        • 8.4.7.3. Market Size and Forecast, By Test Type
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Blood Group Typing Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Technique
        • 8.4.8.3. Market Size and Forecast, By Test Type
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Blood Group Typing Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Technique
        • 8.4.9.3. Market Size and Forecast, By Test Type
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Blood Group Typing Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Technique
        • 8.4.10.3. Market Size and Forecast, By Test Type
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Blood Group Typing Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Technique
        • 8.4.11.3. Market Size and Forecast, By Test Type
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Blood Group Typing Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Technique
        • 8.4.12.3. Market Size and Forecast, By Test Type
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Blood Group Typing Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Technique
        • 8.4.13.3. Market Size and Forecast, By Test Type
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Blood Group Typing Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Technique
        • 8.4.14.3. Market Size and Forecast, By Test Type
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Blood Group Typing Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Technique
        • 8.4.15.3. Market Size and Forecast, By Test Type
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Technique

      • 8.5.4. Market Size and Forecast, By Test Type

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Blood Group Typing Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Technique
        • 8.5.7.3. Market Size and Forecast, By Test Type
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Blood Group Typing Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Technique
        • 8.5.8.3. Market Size and Forecast, By Test Type
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Blood Group Typing Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Technique
        • 8.5.9.3. Market Size and Forecast, By Test Type
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Blood Group Typing Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Technique
        • 8.5.10.3. Market Size and Forecast, By Test Type
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Blood Group Typing Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Technique
        • 8.5.11.3. Market Size and Forecast, By Test Type
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Blood Group Typing Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Technique
        • 8.5.12.3. Market Size and Forecast, By Test Type
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Bio-Rad Laboratories, Inc. (U.S.)

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Grifols, S.A. (Spain)

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Immucor, Inc. (U.S.)

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Ortho Clinical Diagnostics, Inc. (U.S.)

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Quotient, Ltd. (U.S.)

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Novacyt Group (France)

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. BAG Healthcare GmbH (Germany)

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Rapid Labs (U.K.)

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Day Medical SA (Switzerland)

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. DIAGAST (France)

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

    • 10.11. AXO Science (France)

      • 10.11.1. Company Overview

      • 10.11.2. Key Executives

      • 10.11.3. Company Snapshot

      • 10.11.4. Operating Business Segments

      • 10.11.5. Product Portfolio

      • 10.11.6. Business Performance

      • 10.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD GROUP TYPING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL BLOOD GROUP TYPING MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET FOR PCR-BASED AND MICROARRAY TECHNIQUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET FOR ASSAY-BASED TECHNIQUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET FOR MASSIVELY PARALLEL SEQUENCING TECHNIQUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET FOR OTHER TECHNIQUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET FOR ANTIBODY SCREENING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET FOR HLA TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET FOR CROSS-MATCHING TESTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET FOR ABO BLOOD TESTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET FOR ANTIGEN TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET FOR BLOOD BANKS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET FOR OTHER END USERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA BLOOD GROUP TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 29. U.S. BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 30. U.S. BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. CANADA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. CANADA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 33. CANADA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 34. CANADA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE BLOOD GROUP TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ITALY BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. ITALY BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 54. ITALY BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 55. ITALY BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. UK BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. UK BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 62. UK BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 63. UK BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 67. RUSSIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 71. REST OF EUROPE BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC BLOOD GROUP TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 76. ASIA-PACIFIC BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. CHINA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. CHINA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 79. CHINA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 80. CHINA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. INDIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 86. INDIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 87. INDIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 88. INDIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 96. AUSTRALIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 100. THAILAND BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 104. MALAYSIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 108. INDONESIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA BLOOD GROUP TYPING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 117. LAMEA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 125. SOUTH AFRICA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 129. SAUDI ARABIA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 130. UAE BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 131. UAE BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 132. UAE BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 133. UAE BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 137. ARGENTINA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA BLOOD GROUP TYPING, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA BLOOD GROUP TYPING, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA BLOOD GROUP TYPING, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 141. REST OF LAMEA BLOOD GROUP TYPING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 142. BIO-RAD LABORATORIES, INC. (U.S.): KEY EXECUTIVES
  • TABLE 143. BIO-RAD LABORATORIES, INC. (U.S.): COMPANY SNAPSHOT
  • TABLE 144. BIO-RAD LABORATORIES, INC. (U.S.): OPERATING SEGMENTS
  • TABLE 145. BIO-RAD LABORATORIES, INC. (U.S.): PRODUCT PORTFOLIO
  • TABLE 146. BIO-RAD LABORATORIES, INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. GRIFOLS, S.A. (SPAIN): KEY EXECUTIVES
  • TABLE 148. GRIFOLS, S.A. (SPAIN): COMPANY SNAPSHOT
  • TABLE 149. GRIFOLS, S.A. (SPAIN): OPERATING SEGMENTS
  • TABLE 150. GRIFOLS, S.A. (SPAIN): PRODUCT PORTFOLIO
  • TABLE 151. GRIFOLS, S.A. (SPAIN): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. IMMUCOR, INC. (U.S.): KEY EXECUTIVES
  • TABLE 153. IMMUCOR, INC. (U.S.): COMPANY SNAPSHOT
  • TABLE 154. IMMUCOR, INC. (U.S.): OPERATING SEGMENTS
  • TABLE 155. IMMUCOR, INC. (U.S.): PRODUCT PORTFOLIO
  • TABLE 156. IMMUCOR, INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): KEY EXECUTIVES
  • TABLE 158. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): COMPANY SNAPSHOT
  • TABLE 159. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): OPERATING SEGMENTS
  • TABLE 160. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): PRODUCT PORTFOLIO
  • TABLE 161. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. QUOTIENT, LTD. (U.S.): KEY EXECUTIVES
  • TABLE 163. QUOTIENT, LTD. (U.S.): COMPANY SNAPSHOT
  • TABLE 164. QUOTIENT, LTD. (U.S.): OPERATING SEGMENTS
  • TABLE 165. QUOTIENT, LTD. (U.S.): PRODUCT PORTFOLIO
  • TABLE 166. QUOTIENT, LTD. (U.S.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. NOVACYT GROUP (FRANCE): KEY EXECUTIVES
  • TABLE 168. NOVACYT GROUP (FRANCE): COMPANY SNAPSHOT
  • TABLE 169. NOVACYT GROUP (FRANCE): OPERATING SEGMENTS
  • TABLE 170. NOVACYT GROUP (FRANCE): PRODUCT PORTFOLIO
  • TABLE 171. NOVACYT GROUP (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. BAG HEALTHCARE GMBH (GERMANY): KEY EXECUTIVES
  • TABLE 173. BAG HEALTHCARE GMBH (GERMANY): COMPANY SNAPSHOT
  • TABLE 174. BAG HEALTHCARE GMBH (GERMANY): OPERATING SEGMENTS
  • TABLE 175. BAG HEALTHCARE GMBH (GERMANY): PRODUCT PORTFOLIO
  • TABLE 176. BAG HEALTHCARE GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. RAPID LABS (U.K.): KEY EXECUTIVES
  • TABLE 178. RAPID LABS (U.K.): COMPANY SNAPSHOT
  • TABLE 179. RAPID LABS (U.K.): OPERATING SEGMENTS
  • TABLE 180. RAPID LABS (U.K.): PRODUCT PORTFOLIO
  • TABLE 181. RAPID LABS (U.K.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. DAY MEDICAL SA (SWITZERLAND): KEY EXECUTIVES
  • TABLE 183. DAY MEDICAL SA (SWITZERLAND): COMPANY SNAPSHOT
  • TABLE 184. DAY MEDICAL SA (SWITZERLAND): OPERATING SEGMENTS
  • TABLE 185. DAY MEDICAL SA (SWITZERLAND): PRODUCT PORTFOLIO
  • TABLE 186. DAY MEDICAL SA (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 187. DIAGAST (FRANCE): KEY EXECUTIVES
  • TABLE 188. DIAGAST (FRANCE): COMPANY SNAPSHOT
  • TABLE 189. DIAGAST (FRANCE): OPERATING SEGMENTS
  • TABLE 190. DIAGAST (FRANCE): PRODUCT PORTFOLIO
  • TABLE 191. DIAGAST (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 192. AXO SCIENCE (FRANCE): KEY EXECUTIVES
  • TABLE 193. AXO SCIENCE (FRANCE): COMPANY SNAPSHOT
  • TABLE 194. AXO SCIENCE (FRANCE): OPERATING SEGMENTS
  • TABLE 195. AXO SCIENCE (FRANCE): PRODUCT PORTFOLIO
  • TABLE 196. AXO SCIENCE (FRANCE): KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD GROUP TYPING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BLOOD GROUP TYPING MARKET
  • FIGURE 3. SEGMENTATION BLOOD GROUP TYPING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BLOOD GROUP TYPING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBLOOD GROUP TYPING MARKET
  • FIGURE 11. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. BLOOD GROUP TYPING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. BLOOD GROUP TYPING MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. BLOOD GROUP TYPING MARKET FOR SERVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY TECHNIQUE
  • FIGURE 16. BLOOD GROUP TYPING MARKET FOR PCR-BASED AND MICROARRAY TECHNIQUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. BLOOD GROUP TYPING MARKET FOR ASSAY-BASED TECHNIQUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. BLOOD GROUP TYPING MARKET FOR MASSIVELY PARALLEL SEQUENCING TECHNIQUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. BLOOD GROUP TYPING MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY TEST TYPE
  • FIGURE 21. BLOOD GROUP TYPING MARKET FOR ANTIBODY SCREENING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. BLOOD GROUP TYPING MARKET FOR HLA TYPING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. BLOOD GROUP TYPING MARKET FOR CROSS-MATCHING TESTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. BLOOD GROUP TYPING MARKET FOR ABO BLOOD TESTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. BLOOD GROUP TYPING MARKET FOR ANTIGEN TYPING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. BLOOD GROUP TYPING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. BLOOD GROUP TYPING MARKET FOR BLOOD BANKS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. BLOOD GROUP TYPING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. BLOOD GROUP TYPING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 34. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 35. COMPETITIVE DASHBOARD
  • FIGURE 36. COMPETITIVE HEATMAP: BLOOD GROUP TYPING MARKET
  • FIGURE 37. Top player positioning, 2022
  • FIGURE 38. BIO-RAD LABORATORIES, INC. (U.S.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. BIO-RAD LABORATORIES, INC. (U.S.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. BIO-RAD LABORATORIES, INC. (U.S.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. GRIFOLS, S.A. (SPAIN): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. GRIFOLS, S.A. (SPAIN): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. GRIFOLS, S.A. (SPAIN): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. IMMUCOR, INC. (U.S.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. IMMUCOR, INC. (U.S.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. IMMUCOR, INC. (U.S.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. QUOTIENT, LTD. (U.S.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. QUOTIENT, LTD. (U.S.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. QUOTIENT, LTD. (U.S.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. NOVACYT GROUP (FRANCE): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. NOVACYT GROUP (FRANCE): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. NOVACYT GROUP (FRANCE): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. BAG HEALTHCARE GMBH (GERMANY): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. BAG HEALTHCARE GMBH (GERMANY): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. BAG HEALTHCARE GMBH (GERMANY): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. RAPID LABS (U.K.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. RAPID LABS (U.K.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. RAPID LABS (U.K.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. DAY MEDICAL SA (SWITZERLAND): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. DAY MEDICAL SA (SWITZERLAND): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. DAY MEDICAL SA (SWITZERLAND): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 65. DIAGAST (FRANCE): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 66. DIAGAST (FRANCE): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 67. DIAGAST (FRANCE): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 68. AXO SCIENCE (FRANCE): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 69. AXO SCIENCE (FRANCE): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 70. AXO SCIENCE (FRANCE): REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Blood Group Typing Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers